Fertility Preservation for Young Female Cancer Patients

被引：0

作者：

Maltaris, Theodoros ^{[1
]}

Beckmann, Matthias W. ^{[1
]}

Dittrich, Ralf ^{[1
]}

机构：

[1] Univ Erlangen Nurnberg, OB GYN, Univ Hosp Erlangen, Dept Obstet & Gynecol, D-91054 Erlangen, Germany

来源：

IN VIVO | 2009年 / 23卷 / 01期

关键词：

Fertility preservation; ovarian tissue cryopreservation; GnRH analogs; oocyte cryopreservation; ovarian tissue transplantation; review; CRYOPRESERVED OVARIAN TISSUE; COMBINED IMMUNODEFICIENT MICE; BREAST-CANCER; HODGKINS-DISEASE; CHILDHOOD-CANCER; COMBINATION CHEMOTHERAPY; PRIMORDIAL FOLLICLES; ORAL-CONTRACEPTIVES; ADJUVANT TREATMENT; OOCYTE APOPTOSIS;

D O I：

暂无

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Young female cancer patients are still being poorly counseled with regard to the negative impact Of treatment on their fertility and on their options for fertility preservation. Today, many possibilities exist for fertility preservation, such as ovarian suppression with GnRH analogues, ovarian tissue cryopreservation, in vitro maturation or IVF after ovulation induction with aromatase inhibitors. A pregnancy after cancer treatment does not seem to limit the prognosis. This review focuses on both the effect of cancer treatments on fertility and on the various assisted-reproduction innovations that are available to provide the cancer patient with the option of future pregnancies. It is currently a time of uncertainty and revolution concerning the role of ovarian suppression and other fertility preservation measures in the management of early breast cancer, but developments in the near future promise to be very exciting.

引用

页码：123 / 130

页数：8

共 77 条

[1] Two successful pregnancies following autotransplantation of frozen/thawed ovarian tissue [J].

Andersen, Claus Yding ;

Rosendahl, Mikkel ;

Byskov, Anne Grete ;

Loft, Anne ;

Ottosen, Christian ;

Dueholm, Margit ;

Schmidt, Kirsten L. T. ;

Andersen, Anders Nyboe ;

Ernst, Erik .

HUMAN REPRODUCTION, 2008, 23 (10) :2266-2272

[2] Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: A report from the German Hodgkin's lymphoma study group [J].

Behringer, K ;

Breuer, K ;

Reineke, T ;

May, M ;

Nogova, L ;

Klimm, B ;

Schmitz, T ;

Wildt, L ;

Diehl, V ;

Engert, A .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (30) :7555-7564

[3]

Blatt J, 1999, MED PEDIATR ONCOL, V33, P29, DOI 10.1002/(SICI)1096-911X(199907)33:1<29::AID-MPO6>3.0.CO

[4]

2-2

[5] Preservation of fertility and ovarian function and minimalization of chemotherapy associated gonadotoxicity and premature ovarian failure: the role of inhibin-A and -B as markers [J].

Blumenfeld, Z .

MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2002, 187 (1-2) :93-105

[6] How to preserve fertility in young women exposed to chemotherapy? The role of GnRH agonist cotreatment in addition to Cryopreservation of embrya, oocytes, or ovaries [J].

Blumenfeld, Zeev .

ONCOLOGIST, 2007, 12 (09) :1044-1054

[7]

CHAPMAN RM, 1981, BLOOD, V58, P849

[8] Prospective randomized study of human chorionic gonadotrophin priming before immature oocyte retrieval from unstimulated women with polycystic ovarian syndrome [J].

Chian, RC ;

Buckett, WM ;

Tulandi, T ;

Tan, SL .

HUMAN REPRODUCTION, 2000, 15 (01) :165-170

[9]

Chiarelli AM, 1999, AM J EPIDEMIOL, V150, P245

[10] HYPOTHALAMIC PITUITARY DYSFUNCTION AFTER RADIATION FOR BRAIN-TUMORS [J].

CONSTINE, LS ;

WOOLF, PD ;

CANN, D ;

MICK, G ;

MCCORMICK, K ;

RAUBERTAS, RF ;

RUBIN, P .

NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (02) :87-94

← 1 2 3 4 5 6 7 8 →